- Home
- NEWT vs CATX Comparison
NEWT vs CATX Comparison
Compare NEWT & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEWT | CATX |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 400.6M | 341.0M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NEWT | CATX |
|---|---|---|
| Price | $12.57 | $3.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $15.33 | $12.11 |
| AVG Volume (30 Days) | 217.7K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.00% | N/A |
| EPS Growth | ★ 11.22 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.45 | N/A |
| P/E Ratio | $14.21 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.59 | $1.96 |
| 52 Week High | $15.69 | $6.16 |
Technical Indicators
Market Signals| Indicator | NEWT | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 32.31 | 64.17 |
| Support Level | $12.58 | $2.82 |
| Resistance Level | $14.27 | $3.78 |
| Average True Range (ATR) | 0.48 | 0.17 |
| MACD | -0.18 | 0.05 |
| Stochastic Oscillator | 2.69 | 90.30 |
Price Performance
Historical ComparisonAbout NEWT NewtekOne Inc.
NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.